University of Denver
The Case for Extending Patent Terms for Drugs That Treat Rare Diseases
Abstract
dc:description.abstractThis paper seeks to determine if extended patent terms can positively effect the production of drugs that treat rare diseases. It reviews the structure of the modern pharmaceutical company and considers the regulatory history that lead to this structure. The paper applies historically significant economic research in the field of patents and considers patent alternatives to establish the best method for incentivizing the development of these drugs. The paper finds that while there are numerous pitfalls and issues with the patent method, there are no viable alternatives. It also concludes that extending patent terms for drugs that treat rare diseases can act as a catalyst to orphan drug development.
Degree
thesis:*- Name thesis:degree_name
- M.A.
- Level thesis:degree_level
- Masters Thesis
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Thompson, Joanna Louise
- Contributors dc:contributor
-
- Peter Ho, Ph.D.
- Markus Schneider
- Yavuz Yasar
Subjects
dc:subject × 5Rights
dc:rights- Statement dc:rights
-
- <p>Copyright is held by the author. User is responsible for all copyright compliance.</p>
- Joanna Louise Thompson
- Language dc:language
- en
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://digitalcommons.du.edu/etd/648